Radiopharm Theranostics (RADX)

• Market cap: $34.1M
• 1 day: -6.7%
• 5 days: -4%
• 1 month: -5.88%
• 3 months: -7.49%
• 6 months: -9.05%
• Year to date: -16.28%
• 1 year: -9.81%
• 5 years: -75.55%
• 10 years: -75.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Employees: 14